Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-84.97M -43.55M -28.48M -13.11M
Depreciation & Amortization
412K 355K 147K 2.02M
Stock-Based Compensation
12.89M 2.9M 1.52M 63K
Other Working Capital
-8.54M -959K 229K -301K
Other Non-Cash Items
-6.17M -762K -606K -48.82M
Deferred Income Tax
n/a -661K n/a -2.82M
Change in Working Capital
-351K 4.86M -1.65M 3.14M
Operating Cash Flow
-78.18M -36.86M -29.07M -59.53M
Capital Expenditures
-105K -110K -139K -33K
Cash Acquisitions
n/a n/a -175K -1.23M
Purchase of Investments
-413.71M -57.42M -61.68M -45.31M
Sales Maturities Of Investments
127M 77.78M 2M 90M
Other Investing Acitivies
n/a n/a 175K n/a
Investing Cash Flow
-286.81M 20.25M -59.82M 43.43M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-13.57M 61.57M -3.32M n/a
Financial Cash Flow
255.62M 133.57M 96.68M 89.6M
Net Cash Flow
-109.37M 116.97M -116.28M 73.5M
Free Cash Flow
-78.28M -36.97M -29.21M -9.94M